Nifty

:

24102.90

Sensex

:

77094.07

89.80 (0.37%)
291.17 (0.38%)

Login

Nifty
Sensex

:
:

24102.90
77094.07

89.80 (0.37%)
291.17 (0.38%)

Novartis India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

75/99

BSE: 500672 | NSE: NOVARTIND

Watchlist

NSE BSE

1491.70

22-Jun-2026

Open
High
Low
Previous Close

1395
1519
1388.9
1388.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

53909
79334109.1
1589.2
950

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,681.03
39.50
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,013.33
N/A
4.50

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-6.39
-1.35
-2.02

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.49
28.90
7.03

PAT CAGR (%)

10 Years
5 Years
3 Years

-6.53
37.01
-0.80

P:E (Median)

8 Years
5 Years
3 Years

29.88
26.68
24.84

P:BV (Average)

8 Years
5 Years
3 Years

2.64
2.77
3.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.89
14.64
13.57

Earnings Forecasts:

(Updated: 23-06-2026)

Description 2026 2027 2028 2029
Adj EPS - - - -
P/E Ratio - - - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 90.55 83.88 7.95% 85.90 93.00 -7.63% 90.33 87.10 3.71% 87.55 92.29 -5.14%
Expenses 69.93 59.97 16.61% 63.54 67.42 -5.75% 66.45 69.14 -3.89% 60.31 68.32 -11.72%
EBITDA 20.62 23.91 -13.76% 22.36 25.58 -12.59% 23.88 17.96 32.96% 27.24 23.97 13.64%
EBIDTM 22.77% 28.50% 26.03% 27.51% 26.44% 20.62% 31.11% 25.97%
Other Income 10.01 10.63 -5.83% 8.75 10.60 -17.45% 9.40 10.32 -8.91% 10.61 10.41 1.92%
Interest 0.07 0.12 -41.67% 0.98 0.36 172.22% 0.11 0.14 -21.43% 0.10 0.15 -33.33%
Depreciation 0.42 0.53 -20.75% 0.48 0.53 -9.43% 0.52 0.58 -10.34% 0.53 0.55 -3.64%
PBT 30.14 33.89 -11.07% 29.65 35.29 -15.98% 32.65 27.56 18.47% 37.22 33.68 10.51%
Tax 4.89 4.59 6.54% 13.56 9.84 37.80% 8.43 7.15 17.90% 9.60 7.94 20.91%
PAT 25.25 29.30 -13.82% 16.09 25.45 -36.78% 24.22 20.41 18.67% 27.62 25.74 7.30%
PATM 27.89% 34.93% 18.73% 27.37% 26.81% 23.43% 31.55% 27.89%
EPS 10.22 11.86 -13.83% 6.51 10.30 -36.80% 9.81 8.26 18.77% 11.18 10.42 7.29%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 354.33 356.27 335.07 378.74 399.87 381.35 438.25 490.68 563.89 656.22 689.77 Net Sales Growth -0.54% 6.33% -11.53% -5.28% 4.86% -12.98% -10.69% -12.98% -14.07% -4.86% Cost Of Goods Sold 198.37 202.82 199.84 201.69 178.14 146.61 182.32 198.65 245.51 306.10 286.31 Gross Profit 155.96 153.45 135.23 177.05 221.73 234.74 255.93 292.03 318.38 350.12 403.46 GP Margin 44.02% 43.07% 40.36% 46.75% 55.45% 61.56% 58.40% 59.52% 56.46% 53.35% 58.49% Total Expenditure 260.23 264.85 269.81 313.66 373.12 355.66 426.51 478.54 572.12 631.70 658.95 Power & Fuel Cost - 0.14 0.18 0.35 0.53 0.53 1.27 1.79 2.56 1.77 4.43 % Of Sales - 0.04% 0.05% 0.09% 0.13% 0.14% 0.29% 0.36% 0.45% 0.27% 0.64% Employee Cost - 18.72 22.96 35.64 101.89 108.51 113.87 117.11 144.53 139.30 156.66 % Of Sales - 5.25% 6.85% 9.41% 25.48% 28.45% 25.98% 23.87% 25.63% 21.23% 22.71% Manufacturing Exp. - 11.08 7.54 15.51 34.49 36.52 39.23 42.21 42.07 49.03 62.35 % Of Sales - 3.11% 2.25% 4.10% 8.63% 9.58% 8.95% 8.60% 7.46% 7.47% 9.04% General & Admin Exp. - 12.44 15.37 17.09 18.61 12.95 23.40 43.28 45.74 45.74 47.65 % Of Sales - 3.49% 4.59% 4.51% 4.65% 3.40% 5.34% 8.82% 8.11% 6.97% 6.91% Selling & Distn. Exp. - 10.58 15.87 27.98 35.66 39.77 53.99 60.29 72.48 75.83 70.74 % Of Sales - 2.97% 4.74% 7.39% 8.92% 10.43% 12.32% 12.29% 12.85% 11.56% 10.26% Miscellaneous Exp. - 9.07 8.05 15.40 3.80 10.77 12.43 15.21 19.23 13.93 70.74 % Of Sales - 2.55% 2.40% 4.07% 0.95% 2.82% 2.84% 3.10% 3.41% 2.12% 4.47% EBITDA 94.10 91.42 65.26 65.08 26.75 25.69 11.74 12.14 -8.23 24.52 30.82 EBITDA Margin 26.56% 25.66% 19.48% 17.18% 6.69% 6.74% 2.68% 2.47% -1.46% 3.74% 4.47% Other Income 38.77 41.96 61.68 58.11 33.55 34.19 36.43 78.40 173.81 71.52 244.55 Interest 1.26 0.77 1.49 1.75 4.83 7.68 6.39 1.59 5.53 0.72 0.21 Depreciation 1.95 2.19 2.61 6.06 9.65 12.16 13.14 3.18 2.53 3.59 3.49 PBT 129.66 130.42 122.84 115.38 45.82 40.04 28.64 85.77 157.52 91.73 271.67 Tax 36.48 29.52 37.65 12.02 -0.10 19.14 18.56 34.00 79.16 34.51 73.38 Tax Rate 28.14% 22.63% 30.65% 10.42% 2.62% 47.80% 64.80% 39.64% 50.25% 37.62% 27.01% PAT 93.18 100.90 85.19 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 PAT before Minority Interest 93.18 100.90 85.19 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 26.30% 28.32% 25.42% 27.29% -0.93% 5.48% 2.30% 10.55% 13.90% 8.72% 28.75% PAT Growth -7.65% 18.44% -17.58% - - 107.34% -80.53% -33.93% 36.95% -71.14% EPS 37.72 40.85 34.49 41.85 -1.51 8.46 4.08 20.96 31.72 23.17 80.28

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 784.96 744.82 775.66 691.70 711.19 720.73 759.19 733.64 919.64 1,193.58 Share Capital 12.34 12.34 12.34 12.34 12.34 12.34 12.34 12.34 14.07 15.98 Total Reserves 772.62 732.48 763.36 681.58 701.80 711.68 751.10 727.48 913.00 1,184.54 Non-Current Liabilities 696.83 716.25 1,007.77 984.00 1,130.65 99.38 891.47 897.75 827.53 26.47 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 708.90 726.33 998.39 991.58 1,109.57 65.93 909.70 916.30 844.46 45.85 Current Liabilities 426.12 399.83 268.26 334.47 357.26 416.93 367.22 481.74 323.21 204.49 Trade Payables 51.47 61.59 59.67 72.20 55.20 72.60 91.40 106.11 73.22 69.66 Other Current Liabilities 24.83 33.54 38.03 45.34 69.64 132.99 67.62 184.52 63.26 88.94 Short Term Borrowings 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 349.82 304.68 170.56 216.93 232.42 211.34 208.20 191.11 186.73 45.89 Total Liabilities 1,907.91 1,860.90 2,051.69 2,010.17 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 Net Block 4.54 6.94 19.25 23.65 63.91 76.28 14.98 4.60 5.71 6.48 Gross Block 9.08 28.36 38.92 40.71 74.81 85.08 23.93 12.09 10.82 9.87 Accumulated Depreciation 4.54 21.42 19.67 17.06 10.90 8.80 8.95 7.49 5.11 3.39 Non Current Assets 878.02 919.01 1,265.59 1,183.39 1,276.75 239.77 1,029.20 1,008.86 958.91 160.85 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.45 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 870.18 903.63 1,240.75 1,148.65 1,186.01 137.84 989.61 979.98 935.98 153.29 Other Non Current Assets 3.30 8.44 5.59 11.09 26.83 25.65 24.61 24.28 17.21 0.63 Current Assets 1,029.89 941.89 786.06 825.87 922.35 997.27 988.68 1,104.27 1,111.47 1,263.69 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 41.11 44.86 54.72 57.07 47.95 58.68 60.51 56.56 87.52 72.40 Sundry Debtors 40.14 41.47 36.16 44.56 38.73 37.60 45.59 43.91 40.83 50.17 Cash & Bank 648.03 596.08 555.94 517.63 498.88 581.91 612.02 775.08 815.72 1,125.55 Other Current Assets 300.61 2.04 15.95 15.49 336.79 319.08 270.56 228.72 167.40 15.57 Short Term Loans & Adv. 298.14 257.44 123.29 191.12 290.49 259.99 236.02 202.29 146.86 9.99 Net Current Assets 603.77 542.06 517.80 491.40 565.09 580.34 621.46 622.53 788.26 1,059.20 Total Assets 1,907.91 1,860.90 2,051.65 2,009.26 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 74.57 113.40 44.80 38.67 -69.21 -23.14 -194.28 160.99 -40.83 56.59 PBT 130.42 122.84 115.38 -3.82 40.04 28.64 85.77 157.52 91.73 111.37 Adjustment -38.80 -56.75 -48.92 -5.64 -4.98 -11.80 -72.66 -55.87 -55.95 -67.04 Changes in Working Capital -0.76 9.04 -24.00 66.72 -69.08 -1.85 -161.76 117.30 -32.45 91.70 Cash after chg. in Working capital 90.86 75.13 42.46 57.26 -34.02 14.99 -148.65 218.95 3.33 136.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.29 38.27 2.34 -18.59 -35.19 -38.13 -45.63 -57.96 -44.16 -79.44 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -3.31 33.13 -153.25 87.04 95.16 55.91 274.23 68.70 423.64 -630.47 Net Fixed Assets 19.28 10.56 1.79 34.10 10.27 -61.15 -11.84 -1.26 -0.51 15.76 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Others -22.59 22.57 -155.04 52.94 84.89 117.06 286.07 69.96 424.15 -646.24 Cash from Financing Activity -64.15 -120.99 -30.48 -35.63 -36.80 -41.41 -29.82 -267.65 -331.80 -38.57 Net Cash Inflow / Outflow 7.11 25.54 -138.93 90.08 -10.85 -8.64 50.13 -37.96 51.01 -612.45 Opening Cash & Equivalents 44.96 19.42 158.35 68.27 79.12 87.76 37.63 75.59 24.58 637.03 Closing Cash & Equivalent 52.07 44.96 19.42 158.35 68.27 79.12 87.76 37.63 75.59 24.58

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 318.06 301.79 314.30 281.17 289.36 293.36 309.34 299.76 329.45 375.63 ROA 5.35% 4.35% 5.09% -0.18% 1.22% 0.62% 2.51% 3.75% 3.27% 11.38% ROE 13.19% 11.21% 14.07% -0.53% 2.91% 1.36% 6.89% 9.40% 5.38% 18.01% ROCE 17.15% 16.35% 15.96% 0.14% 6.67% 4.73% 11.70% 19.72% 8.75% 24.77% Fixed Asset Turnover 20.84 10.90 10.39 8.43 5.68 9.77 32.72 59.76 63.43 38.38 Receivable days 38.18 38.62 35.62 31.23 30.70 28.50 27.72 22.59 25.31 35.20 Inventory Days 40.22 49.54 49.34 39.38 42.89 40.83 36.25 38.41 44.47 45.59 Payable days 101.73 110.74 119.32 130.52 159.09 74.34 84.28 68.27 44.09 50.69 Cash Conversion Cycle -23.33 -22.58 -34.36 -59.90 -85.49 -5.01 -20.31 -7.27 25.70 30.10 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 170.38 83.44 66.93 0.21 6.21 5.48 54.94 29.48 128.40 1294.67

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Novartis India launches precision radiotherapy ‘Pluvicto’ for prostate cancer
15th Jun 2026, 15:59 PM

Pluvicto is the country's first regulatory authority-approved radioligand therapy for PSMA -positive prostate cancer
Read More
Novartis - Quarterly Results
13th May 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback